MELROSE HEALTH LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (54/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (4 events)Click to expand
- 2025-08-26📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-03-20🏢Company incorporatedAs MELROSE HEALTH LTD
- 2025-03-20➕FRENCH, Amy Josephine appointeddirector
- 2025-03-20📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.3 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Amy Josephine French Individual · British · DOB 11/1982 · age 44 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 20/03/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · TD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| LASER VISION SCOTLAND LTD→ SC448890 · est 2013 | £11.07M £7.97M–£14.18M | £13.54M | — | 7500 | 13y | 84 | 58y |
| AKAM CARE LIMITED→ SC379940 · est 2010 | — | — | £249.4k | — | 16y | 82 | 62y |
| SCOTIA CHIROPRACTIC LIMITED→ SC138934 · est 1992 | — | — | £105.9k | — | 33y | 82 | 64y |
| BORDERS INDEPENDENT ADVOCACY SERVICE→ SC281185 · est 2005 · no financials extracted | — | — | — | — | 21y | 81 | 77y |
| CENTRAL BORDERS CITIZENS ADVICE BUREAU→ SC217973 · est 2001 | — | — | — | 7 | 25y | 81 | 79y |
| STREETS AHEAD (BORDERS)→ SC105923 · est 1987 | — | — | — | 142 | 38y | 81 | 77y |
| FLEXIBLE RESPITE LTD→ SC504233 · est 2015 | — | — | — | 1800 | 11y | 79 | 63y |
| FOSTER CARE CONNECT LTD.→ SC261956 · est 2004 | — | — | £610.4k | — | 22y | 79 | 59y |
| FTS CARE LTD→ SC355267 · est 2009 | — | — | — | 3800 | 17y | 79 | 62y |
| MELROSE GASTROENTEROLOGY LIMITED→ SC524745 · est 2016 | — | — | £5.0k | — | 10y | 79 | 63y |
| PRYCE & CO LIMITED→ SC157925 · est 1995 | — | — | £480.1k | — | 31y | 79 | 79y |
| BERWICK CARE HOMES LIMITED→ 03092064 · est 1995 | — | — | £1.37M | — | 30y | 78 | 61y |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.